rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - artrita, reumatoida - imunosupresoare - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
bimzelx
ucb pharma s.a. - bimekizumab - psoriazis - imunosupresoare - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale pentru uz sistemic - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 și 5. tecovirimat siga should be used in accordance with official recommendations.
imudon comprimate de supt
farmstandart-tomschimfarm sad - combinaţie - comprimate de supt
mogulair comprimate filmate 10 mg
welfar united ltd. - montelukastum - comprimate filmate - 10 mg
movalis solutie injectabila 15 mg/1,5 ml
boehringer ingelheim international gmbh - meloxicamum - solutie injectabila - 15 mg/1,5 ml
zostavax
merck sharp & dohme b.v. - virusul varicelo-zoster (viu, atenuat) - herpes zoster; immunization - vaccinuri virale - zostavax este indicat pentru prevenirea herpes zoster (zoster sau herpes zoster) și a nevralgiei postherpetice legate de herpes zoster. zostavax este indicat pentru imunizarea persoanelor cu vârsta de 50 ani sau mai în vârstă.
enrodem 10%, sol.or.
srl delos impex’96, românia - enrofloxacina - soluţie orală - свиные, păsări
funghibac-iam, unguent
Îi o.l.kar-agrozoovet-servis, ucraina - acid - unguent - крупного рогатого скота, cabaline, козлятины, pisici, cîini
lincodem 50
sc delos impex 96 srl,românia - lincomicina - pulbere hidrosolubilă - păsări, свиная